Hanall Biopharma Co., Ltd. (KRX: 009420)
South Korea flag South Korea · Delayed Price · Currency is KRW
31,850
-800 (-2.45%)
Dec 20, 2024, 3:30 PM KST

Hanall Biopharma Market Cap

Hanall Biopharma has a market cap or net worth of 1.62 trillion as of December 20, 2024. Its market cap has decreased by -15.82% in one year.

Market Cap
1.62T
Enterprise Value
1.59T
Revenue
134.24B
Ranking
n/a
PE Ratio
n/a
Stock Price
31,850.00

Market Cap Chart

Since August 30, 1995, Hanall Biopharma's market cap has increased from 26.30B to 1.62T, an increase of 6,041.31%. That is a compound annual growth rate of 15.07%.

History

DateMarket Cap% Change
Dec 20, 20241,615.12B-28.08%
Dec 28, 20232,245.71B148.89%
Dec 29, 2022902.29B-16.29%
Dec 30, 20211,077.89B-43.84%
Dec 30, 20201,919.22B3.31%
Dec 30, 20191,857.72B0.28%
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Dec 30, 2015 Pro Pro
Dec 30, 2014 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition